Alyeska Investment Group’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.9M | Buy |
243,744
+128,691
| +112% | +$2.06M | 0.01% | 439 |
|
|
2025
Q1 | $1.75M | Hold |
115,053
| – | – | 0.01% | 416 |
|
|
2024
Q4 | $2.33M | Sell |
115,053
-75,000
| -39% | -$1.52M | 0.01% | 454 |
|
|
2024
Q3 | $4.89M | Sell |
190,053
-59,947
| -24% | -$1.54M | 0.02% | 357 |
|
|
2024
Q2 | $3.22M | Buy |
250,000
+175,000
| +233% | +$2.25M | 0.02% | 364 |
|
|
2024
Q1 | $1.72M | Buy |
+75,000
| New | +$1.72M | 0.01% | 371 |
|
|
2021
Q3 | – | Sell |
-5,000
| Closed | -$735K | – | 796 |
|
|
2021
Q2 | $735K | Buy |
+5,000
| New | +$735K | 0.01% | 625 |
|